Duration of Virus Shedding After Trivalent Intranasal Live Attenuated Influenza Vaccination in Adults

This publication has 30 references indexed in Scilit:

• Current status of live attenuated influenza virus vaccine in the US
  Virus Research, 2004
• Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children
  The Pediatric Infectious Disease Journal, 2001
• The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children
  New England Journal of Medicine, 1998
• Evaluation of Live Attenuated Influenza Vaccines in Children 6-18 Months of Age: Safety, Immunogenicity, and Efficacy
  The Journal of Infectious Diseases, 1996
• Comparative Trial of Large-Particle Aerosol and Nose Drop Administration of Live Attenuated Influenza Vaccines
  The Journal of Infectious Diseases, 1993
• Trivalent Attenuated Cold-Adapted Influenza Virus Vaccine: Reduced Viral Shedding and Serum Antibody Responses in Susceptible Adults
  The Journal of Infectious Diseases, 1993
• Use of Influenza A Virus Vaccines in Seronegative Children: Live Cold-Adapted Versus Inactivated Whole Virus
  The Journal of Infectious Diseases, 1985
• Dose Response of Influenza A/Washington/897/80 (H3N2) Avian-Human Reassortant Virus in Adult Volunteers
  The Journal of Infectious Diseases, 1985
• Studies with a Cold-Recombinant A/Victoria/3/7S (H3N2) Virus. II. Evaluation in Adult Volunteers
  The Journal of Infectious Diseases, 1980
• Standardized Viral Hemagglutination and Hemagglutination-Inhibition Tests. II. Description and Statistical Evaluation
  Applied Microbiology, 1969